The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
批准号:
10150273
负责人:
Daniel S Perrien
金额:
$40.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Fibrodysplasia ossificans progressiva (FOP) is a rare, currently untreatable, congenital disease in which
skeletal muscle repair is redirected to endochondral bone formation (heterotopic ossification, HO). These
pathologies cause pain, muscle destruction, and joint fusion, leading to progressive immobilization and
eventually premature death. FOP is caused by a mutation in Alk2 (most commonly R206H) that renders the
receptor sensitive to aberrant activation by Activin A (ActA). However, the “flares” that lead to HO appear to be
initiated by inflammatory insults, and HO can be reduced in FOP mice by depletion of inflammatory innate
immune cells including macrophages. Fibroadipoprogenitors (FAPs), residing in the muscle interstitium appear
to be the critical precursors of chondrocytes in FOP. In healthy muscle repair, macrophages secrete TNFα to
trigger apoptosis of FAPs at a precise and critical time in the repair process. However, in injured FOP
muscles, FAPs survive and differentiate into chondrocytes, suggesting their interaction with macrophages is
disrupted. Therefore, this proposal will explore the hypothesis that pro-inflammatory and anti-inflammatory
macrophages are critical sources of cytokines that enable survival and expansion of the chondrogenic
fibroadipoprogenitors in FOP. Specifically, it seeks to determine the critical source(s) of ActA and what
signals pathways in FAPS are disrupted to block their normal apoptotic fate. These studies will be the first to
explore the mechanisms by which macrophages interact with chondrogenic FAPs to support chondrogenesis
and HO, and they will provide critical insights to the early stages of FOP flares.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10434101
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10249238
-
项目类别:
-
资助金额:$42.39万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10168215
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10407678
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10616939
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
Immune cells and cytokines mediating fibrodysplasia ossificans progressiva
-
批准号:8871583
-
项目类别:
-
资助金额:$20.72万
-
财政年份:2015
-
负责人:Daniel S Perrien
-
依托单位:
vivaCT80 - in vivo small animal microCT
-
批准号:8639867
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2014
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8667309
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8774183
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8442139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Novel ultrahigh resolution microCT imaging system
-
批准号:7794779
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2010
-
负责人:Daniel S Perrien
-
依托单位:
国内基金
海外基金
登录
查看更多内容
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
Innate-likeB细胞受损介导凋亡细胞的清除障碍在系统性红斑狼疮发病中的作用及机制研究
-
批准号:81860295
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2018
-
负责人:张伟
-
依托单位:
控制肠道病毒71型感染的先天性免疫保护机制及其应用
-
批准号:31270951
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:冷启彬
-
依托单位:
microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究
-
批准号:31170826
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2011
-
负责人:侯晋
-
依托单位:
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
-
批准号:81171510
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:李若瑜
-
依托单位:
干扰素刺激基因2',3'环核苷酸磷酸二酯酶(CNP)抗病毒特性的研究
-
批准号:31170853
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:蒋栋
-
依托单位:
转录因子IRF3的泛素和SUMO修饰调节机制及其在抗病毒天然免疫中的功能
-
批准号:31130020
-
项目类别:重点项目
-
资助金额:315.0万元
-
批准年份:2011
-
负责人:舒红兵
-
依托单位:
细胞内受体TLR9、NOD1和NOD2在不可分型流感嗜血杆菌肺组织感染中的作用
-
批准号:30670929
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2006
-
负责人:吴晓虹
-
依托单位: